BREAKING NEWS – US FDA Approves Lutetium Lu 177 dotatate (Lutathera®) – PRRT?


BREAKING NEWS for email followers

Ronny Allan - Living with Neuroendocrine Cancer

There’s a lot of questions doing the rounds on forums and messages about the approval of Lutathera (PRRT) in USA, Europe and other places.  The latest we know is in the red print headlines below. Followed by an update of known activity by region/country and a short primer for those not sure about PRRT.

LATEST HEADLINES

USA – 26 Jan 2018. FDA approves Lutetium Lu 177 Dotatate (Lutathera®)   CLICK HERE

See also here
(full guidance will be updated when received)

ALL7 Dec 2017.  Novartis and Advanced Accelerator Applications (AAA) Announced that Novartis is buying AAA and the process has been completed.  AAA is now a Novartis Company.   Read here  This will not have any effect on approval timelines.

EUROPE – 29 Sep 2017.  AAA Announced that the European Commission (EC) has approved the use of Lutetium Lu 177 Dotatate (Lutathera®).  Despite the treatment being used…

View original post 1,384 more words

4 thoughts on “BREAKING NEWS – US FDA Approves Lutetium Lu 177 dotatate (Lutathera®) – PRRT?

Thanks for the comment, make sure you have ticked the box to receive notifications of responses

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.